Duvelisib for Critically-Ill Patients with COVID-19 Disease: An Investigator-Initiated, Randomized, Placebo-Controlled Double-Blind Pilot Trial

被引：0
|
作者：
Goldsmith, Scott R. [1 ]
Covut, Fahrettin [1 ]
Fiala, Mark A. [2 ]
Bradtke, Elizabeth [1 ]
Gasanli, Ayan [1 ]
Christen, Brandon [1 ]
Pachter, Jonathan A. [3 ]
Xiang, Zhifu [1 ]
Iqbal, Zahid [4 ]
Moore, Nathan [5 ]
Ofoma, Uchenna [4 ]
Parikh, Bijal [6 ]
Dubberke, Erik [7 ]
DiPersio, John F. [8 ]
机构：
[1] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Div Hematol & Oncol, Dept Med, St Louis, MO 63110 USA
[3] Verastem, Needham, MA USA
[4] Washington Univ, Sch Med, Dept Anesthesiol, Div Crit Care, St Louis, MO 63110 USA
[5] Missouri Baptist Med Ctr, St Louis, MO USA
[6] Washington Univ, Sch Med, St Louis, MO 63110 USA
[7] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA
[8] Washington Univ, Sch Med, Div Oncol, Dept Internal Med, St Louis, MO 63110 USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-157605
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11185 / 11186
页数：2
相关论文
共 50 条
  • [1] Duvelisib for Critically Ill Patients With Coronavirus Disease 2019: An Investigator-Initiated, Randomized, Placebo-Controlled, Double-Blind Pilot Trial
    Goldsmith, Scott R.
    Covut, Fahrettin
    Fiala, Mark
    Xiang, Zhifu
    Iqbal, Zahid
    Moore, Nathan
    Bradtke, Elizabeth
    Christen, Brandon
    Rettig, Michael P.
    Christ, Stephanie
    Gehrs, Leah
    Street, Emily
    Wallace, Nicholas
    Ritchey, Julie
    Gao, Feng
    Pachter, Jonathan
    Parikh, Bijal
    Dubberke, Erik R.
    Dipersio, John F.
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (11):
  • [2] Efficacy of Alkaline Phosphatase in Critically Ill Patients with COVID-19: A Multicentre Investigator-Initiated Double-Blind Randomised Placebo-Controlled Trial
    Pijpe, Anouk
    Papendorp, Stephan G.
    van der Heijden, Joost W.
    Vermin, Ben
    Ertugrul, Iris
    Ritt, Michael W. J.
    Stessel, Bjorn
    Callebaut, Ina
    Beishuizen, Albertus
    Vlig, Marcel
    Jimmink, Joost
    Huijgen, Henk J.
    van Zuijlen, Paul P. M.
    Middelkoop, Esther
    de Jong, Evelien
    [J]. BIOMEDICINES, 2024, 12 (04)
  • [3] Levocarnitine for vismodegib-associated muscle spasms: a pilot randomized, double-blind, placebo-controlled, investigator-initiated trial
    Cannon, J. G. D.
    Tran, D. C.
    Li, S.
    Chang, A. S.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (07) : E298 - E299
  • [4] Levocarnitine for vismodegib-associated muscle spasms: A pilot randomized, double-blind, placebo-controlled, investigator-initiated trial
    Chang, Anne Lynn
    Cannon, John
    Tran, Duy
    Li, Shufeng
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB178 - AB178
  • [5] Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial
    Kurth, Florian
    Helbig, Elisa T.
    Lippert, Lena J.
    Thibeault, Charlotte
    Barbone, Gianluca
    Eckart, Marius A.
    Kluge, Martin
    Puengel, Tobias
    Demir, Muenevver
    Roehle, Robert
    Keller, Theresa
    Ruwwe-Gloesenkamp, Christoph
    Witzenrath, Martin
    Suttorp, Norbert
    von Kalle, Christof
    Sander, Leif E.
    Jochum, Christoph
    Tacke, Frank
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2023, 32 : 44 - 47
  • [6] A multicentre, double-blind, placebo-controlled randomized trial of Mycobacterium w in critically ill patients with COVID-19 (ARMY-2)
    Sehgal, Inderpaul S.
    Agarwal, Ritesh
    Jindal, Atul
    Siddiqui, Md Sabah
    Mohan, Anant
    Pal, Arnab
    Guleria, Randeep
    Bhalla, Ashish
    Kajal, Kamal
    Malhotra, Pankaj
    Puri, Goverdhan Dutt
    Khadanga, Sagar
    Joshi, Rajnish
    Singh, Sarman
    Saigal, Saurabh
    Nagarkar, Nitin M.
    Suri, Vikas
    Bhatnagar, Sushma
    Tiwari, Pawan
    Singh, Mini P.
    Yaddanapudi, Laxmi Narayana
    Mittal, Saurabh
    Chauhan, Anshika
    Banerjee, Gaurab
    Rai, Deependra K.
    Gupta, Bikram K.
    [J]. LUNG INDIA, 2024, 41 (02) : 84 - 92
  • [7] Efficacy of prucalopride in critically ill patients with paralytic ileus: A pilot randomized double-blind placebo-controlled trial
    Jandee, Sawangpong
    Wetwittayakhlang, Panu
    Boonsri, Pattira
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (02) : 362 - 366
  • [8] Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial
    Alberda, Cathy
    Gramlich, Leah
    Meddings, Jon
    Field, Catherine
    McCargar, Linda
    Kutsogiannis, Demetrios
    Fedorak, Richard
    Madsen, Karen
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 85 (03): : 816 - 823
  • [9] Safety and efficacy of rituximab in systemic sclerosis (DESIRES): a double-blind, investigator-initiated, randomised, placebo-controlled trial
    Ebata, Satoshi
    Yoshizaki, Ayumi
    Oba, Koji
    Kashiwabara, Kosuke
    Ueda, Keiko
    Uemura, Yukari
    Watadani, Takeyuki
    Fukasawa, Takemichi
    Miura, Shunsuke
    Yoshizaki-Ogawa, Asako
    Asano, Yoshihide
    Okiyama, Naoko
    Kodera, Masanari
    Hasegawa, Minoru
    Sato, Shinichi
    [J]. LANCET RHEUMATOLOGY, 2021, 3 (07): : E489 - E497
  • [10] The effects of colchicine on hospitalized COVID-19 patients: A randomized, double-blind, placebo-controlled clinical trial
    Kasiri, Hossein
    Ghazaiean, Mobin
    Rouhani, Nima
    Naderi-behdani, Fahimeh
    Ghazaeian, Monireh
    Ghodssi-Ghassemabadi, Robabeh
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (02) : 124 - 131
12345